Centessa Pharmaceuticals Plc
CNTA
Revenue
6.85M
▲6.85M∞%
12 Months ChangeAssets
398.85M
▲70.67M▲21.54%
3 Months ChangeLiabilities
111.88M
▼-1.13M▼-0.9982%
3 Months ChangeFree Cash Flow
-37.29M
▲10.64M▲22.20%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-13
Form 8-K
ID: 0001193125-24-218828
2024-09-10
Form 8-K
ID: 0001193125-24-216320
2024-08-13
Form 10-Q
ID: 0001847903-24-000128
2024-08-13
Form 8-K
ID: 0001847903-24-000126
2024-06-25
Form 8-K
ID: 0001847903-24-000095
2024-06-10
Form 8-K
ID: 0001193125-24-157839
2024-05-13
Form 10-Q
ID: 0001847903-24-000081
2024-05-13
Form 8-K
ID: 0001847903-24-000079
2024-04-24
Form 8-K
ID: 0001193125-24-108717
2024-04-22
Form 8-K
ID: 0001847903-24-000069